Molecular-targeted therapy for elderly patients with advanced non-small cell lung cancer (Review)

Author：                  

Publisher： Spandidos Publications

E-ISSN： 1792-1082|11|1|3-8

ISSN： 1792-1074

Source： Oncology Letters, Vol.11, Iss.1, 2016-01, pp. : 3-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vinorelbine Treatment of Advanced Non-small Cell Lung Cancer with Special Emphasis on Elderly Patients

By Veronesi A.   Crivellari D.   Magri M.D.   Cartei G.   Mansutti M.   Foladore S.   Monfardini S.  

European Journal of Cancer, Vol. 32, Iss. 10, 1996-09 ,pp. : 1809-1811

Elsevier

Access to resources Recommend Favorite

Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer

By Maestu I.   Gomez-Aldaravi L.   Torregrosa M.D.   Camps C.   Llorca C.   Bosch C.   Gomez J.   Giner V.   Oltra A.   Albert A.  

Lung Cancer, Vol. 42, Iss. 3, 2003-12 ,pp. : 345-354

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of first-line erlotinib in elderly patients with advanced non-small cell lung cancer

By          

Oncology Reports, Vol. 28, Iss. 2, 2012-01 ,pp. : 721-727

Spandidos Publications

Access to resources Recommend Favorite

Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 5, 2014-06 ,pp. : 646-650

Bentham Science Publishers

Access to resources Recommend Favorite

Advanced non-small cell lung cancer therapy: historical and future perspectives

By Reck M.  

Targeted Oncology, Vol. 3, Iss. 3, 2008-07 ,pp. : 135-147

Springer Publishing Company

Access to resources Recommend Favorite